JP2017518982A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2017518982A5 JP2017518982A5 JP2016567865A JP2016567865A JP2017518982A5 JP 2017518982 A5 JP2017518982 A5 JP 2017518982A5 JP 2016567865 A JP2016567865 A JP 2016567865A JP 2016567865 A JP2016567865 A JP 2016567865A JP 2017518982 A5 JP2017518982 A5 JP 2017518982A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- composition according
- administered
- epiamb
- pharmaceutically acceptable
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201461994450P | 2014-05-16 | 2014-05-16 | |
| US61/994,450 | 2014-05-16 | ||
| US201462045907P | 2014-09-04 | 2014-09-04 | |
| US62/045,907 | 2014-09-04 | ||
| PCT/US2015/030965 WO2015175875A1 (en) | 2014-05-16 | 2015-05-15 | Amphotericin b derivative with reduced toxicity |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2017518982A JP2017518982A (ja) | 2017-07-13 |
| JP2017518982A5 true JP2017518982A5 (enExample) | 2018-06-28 |
| JP6543272B2 JP6543272B2 (ja) | 2019-07-10 |
Family
ID=54480735
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016567865A Active JP6543272B2 (ja) | 2014-05-16 | 2015-05-15 | 低減された毒性を有するアンホテリシンｂ誘導体 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US9738677B2 (enExample) |
| EP (1) | EP3142672B1 (enExample) |
| JP (1) | JP6543272B2 (enExample) |
| CA (1) | CA2981288C (enExample) |
| DK (1) | DK3142672T3 (enExample) |
| ES (1) | ES2749927T3 (enExample) |
| WO (1) | WO2015175875A1 (enExample) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10087206B2 (en) * | 2014-10-17 | 2018-10-02 | The Board Of Trustees Of The University Of Illinois | Scalable synthesis of reduced toxicity derivative of amphotericin B |
| EP3929203A1 (en) | 2015-04-15 | 2021-12-29 | Sfunga Therapeutics, Inc. | Derivatives of amphotericin b |
| KR102893040B1 (ko) | 2018-09-07 | 2025-11-27 | 더 보오드 오브 트러스티스 오브 더 유니버시티 오브 일리노이즈 | 독성이 감소된 혼성 암포테리신 b 유도체 |
| AU2020325163B2 (en) * | 2019-08-08 | 2026-04-23 | The Board Of Trustees Of The University Of Illinois | Hybrid amide derivatives of amphotericin B |
| CA3149819A1 (en) * | 2019-08-08 | 2021-02-11 | The Board Of Trustees Of The University Of Illinois | Hybrid amphotericin b derivatives with reduced toxicity |
| EP4009968A4 (en) * | 2019-08-09 | 2023-08-16 | The Board Of Trustees Of The University Of Illinois | Combination treatment of systemic fungal infections |
| PT4192248T (pt) * | 2020-08-10 | 2026-02-11 | Univ Illinois | Derivados amida híbridos de anfotericina b |
| CA3261962A1 (en) * | 2022-07-08 | 2024-01-11 | The Board Of Trustees Of The University Of Illinois | TRANSFER OF C2 EPIMERIZED SUGARS TO AGLYCONIC AMPHOTEROCIBN B |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7521418B2 (en) | 2003-05-27 | 2009-04-21 | Theravance, Inc. | Use of a polyene macrolide antifungal agent in combination with a glycopeptide antibacterial agent |
| BRPI0512326A (pt) * | 2004-06-21 | 2008-02-26 | Nektar Therapeutics | composições compreendendo anfotericina b, métodos e sistemas |
| US8513204B2 (en) * | 2004-06-21 | 2013-08-20 | Novartis Ag | Compositions comprising amphotericin B, mehods and systems |
| WO2014059436A1 (en) * | 2012-10-12 | 2014-04-17 | The Board Of Trustees Of The University Of Illinois | Electronic tuning of site selectivity |
| US10087206B2 (en) * | 2014-10-17 | 2018-10-02 | The Board Of Trustees Of The University Of Illinois | Scalable synthesis of reduced toxicity derivative of amphotericin B |
-
2015
- 2015-05-15 WO PCT/US2015/030965 patent/WO2015175875A1/en not_active Ceased
- 2015-05-15 DK DK15793421.7T patent/DK3142672T3/da active
- 2015-05-15 US US15/310,815 patent/US9738677B2/en active Active
- 2015-05-15 CA CA2981288A patent/CA2981288C/en active Active
- 2015-05-15 ES ES15793421T patent/ES2749927T3/es active Active
- 2015-05-15 JP JP2016567865A patent/JP6543272B2/ja active Active
- 2015-05-15 EP EP15793421.7A patent/EP3142672B1/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2014507446A5 (enExample) | ||
| JP2017509667A5 (enExample) | ||
| JP2017537066A5 (enExample) | ||
| JP2016518337A5 (enExample) | ||
| JP2024516371A5 (enExample) | ||
| JP2015078230A5 (enExample) | ||
| JP2021191784A5 (enExample) | ||
| JP2018521020A5 (enExample) | ||
| JP2017105793A5 (enExample) | ||
| JP2013014622A5 (enExample) | ||
| JP2013032389A5 (enExample) | ||
| WO2018234568A3 (en) | HYDROXYNORKETAMINE FOR USE IN TREATING DEPRESSION | |
| EP4616908A3 (en) | Oxysterols and methods of use thereof | |
| JP2018531941A5 (enExample) | ||
| JP2014167010A5 (enExample) | ||
| EP3731847A4 (en) | PULSED ADMINISTRATION OF INHALED NITROGEN OXIDE FOR THE TREATMENT OF PULMONIC HYPERTENSION | |
| JP2013519675A5 (enExample) | ||
| JP2016106149A5 (enExample) | ||
| HRP20250119T1 (hr) | Kdm1a inhibitor i njegova primjena u terapiji | |
| EP4663636A3 (en) | Trifluoromethyl substituted pyrazoles as human plasma kallikrein inhibitors | |
| ME02910B (me) | Spojevi tetrahidropirolotiazina | |
| JP2015528502A5 (enExample) | ||
| CL2018001199A1 (es) | Composiciones terapéuticas para el tratamiento del virus de inmunodeficiencia humana | |
| RU2017116740A (ru) | Комбинации для лечения рассеянного склероза | |
| MX2016008665A (es) | Derivado basado en 1,2-naftoquinona y metodo de preparacion del mismo. |